When is the next results date for OneSource Specialty Pharma Ltd?
2026-05-08 23:17:32The next results date for OneSource Specialty Pharma Ltd is scheduled for 13 May 2026....
Read More
OneSource Specialty Pharma Ltd is Rated Sell
2026-04-25 10:10:03OneSource Specialty Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 13 April 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read MoreOneSource Specialty Pharma Surges 17.77%: 2 Key Drivers Behind the Rally
2026-04-25 09:03:12Key Events This Week 20 Apr: Stock opens at Rs.1,547.85 with modest gains despite Sensex dip 21 Apr: High-value trading with 29.54 lakh shares and ₹45,262 lakh turnover 22 Apr: Price jumps 3.19% amid volatile market 23 Apr: Intraday high of Rs.1,718.9 with 9.78% daily gain 24 Apr: Week closes at Rs.1,814.05, up 2.58% on the day Week OpenRs.1,540.35</di...
Read More
OneSource Specialty Pharma Ltd Surges 7.44% to Day's High of Rs 1718.9 — Outperforms Sector by 4.5 Percentage Points
2026-04-23 11:01:02The Sensex declined 0.84% on 23 Apr 2026, while OneSource Specialty Pharma Ltd surged 7.44%, outperforming its Pharmaceuticals & Biotechnology sector by 4.5 percentage points. This strong single-session gain stands out as a stock-specific event amid a broadly weak market backdrop.
Read More
OneSource Specialty Pharma Ltd Sees High-Value Trading Amid Mixed Market Signals
2026-04-21 12:00:07OneSource Specialty Pharma Ltd (ONESOURCE) emerged as one of the most actively traded stocks by value on 21 Apr 2026, registering a total traded volume of 29.54 lakh shares and a turnover exceeding ₹45,262 lakh. Despite this robust trading activity, the stock experienced a modest decline of 0.43% during the session, reflecting a nuanced market sentiment amid shifting investor participation and technical indicators.
Read MoreOneSource Specialty Pharma Gains 7.17%: 4 Key Factors Driving the Week’s Momentum
2026-04-18 09:03:15Key Events This Week 13 Apr: Intraday high of ₹1,550.40 with a 7.35% surge 14 Apr: Mojo Grade upgraded from Strong Sell to Sell 15 Apr: Technical momentum shifts to sideways trend with 7.37% gain 16 Apr: Weekly technical momentum turns mildly bullish despite price dip 17 Apr: Week closes at ₹1,540.35, up 2.28% on the day Week Open₹1,437.30 ...
Read More
OneSource Specialty Pharma Ltd Upgraded to Sell on Technical Improvements Despite Financial Challenges
2026-04-14 08:51:37OneSource Specialty Pharma Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 13 Apr 2026, driven primarily by a shift in technical indicators despite ongoing financial headwinds. The small-cap pharmaceutical company’s Mojo Score improved to 32.0, reflecting a nuanced balance between technical momentum and fundamental weaknesses.
Read More
OneSource Specialty Pharma Ltd Surges 7.35% to Day's High of Rs 1550.4 — Outperforms Sector by 7.73 Percentage Points
2026-04-13 14:31:40The Sensex declined by 0.77% on 13 Apr 2026 while OneSource Specialty Pharma Ltd surged 7.35%, marking a 7.73 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This sharp single-session gain rewrites the short-term narrative for the stock, which has been on a three-day winning streak, accumulating a 15.52% return in that period.
Read MoreOneSource Specialty Pharma Ltd Declines 0.70%: 4 Key Market Moves This Week
2026-03-28 09:04:39Key Events This Week 23 Mar: Intraday low amid price pressure, stock falls 5.00% 24 Mar: Continued intraday decline, stock drops 5.51% despite Sensex gains 25 Mar: Strong intraday rally with 6.99% gain, breaking six-day losing streak 27 Mar: Bearish momentum persists despite 7.10% surge on last trading day Week OpenRs.1,462.45 <div class="stat-lab...
Read MoreGeneral- Update
19-May-2026 | Source : BSEIn furtherance to the intimation dated May 13 2026 w.r.t the resignation of SMP please find enclosed the resignation document.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
19-May-2026 | Source : BSEIntimation of Transcript of Earnings call dated May 13 2026
General-Update
16-May-2026 | Source : BSEWe wish to inform that the Government of Karnataka has accorded in-principle approval for the application submitted by the Company for Unit-II expansion project under the Karnataka Industrial Policy (KIP) 2025-30 towards incentives and concessions.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available